Liao Hong-qing, Lin Ge, Lu Chang-fu, Gong Fei, Xiao Hong-mei, Lu Guang-xiu
Institute of Reproduction and Stem Cell Engineering, Center South University, Changsha 410078, China.
Zhonghua Fu Chan Ke Za Zhi. 2006 May;41(5):319-21.
To evaluate the value of using a combined grading for embryo growth rate and morphology and zygote pronuclear morphology, and to select embryos for transfer in clinical in-vitro fertilization (IVF)/intra-cytoplasmic sperm injection (ICSI).
In this retrospective study, a total of 2714 normal zygotes (2 pronuclei) from 434 treatment cycles with IVF/ICSI was analyzed between May 2003 and December 2003. These zygotes were divided into two groups (synchronous group and nonsynchronous group) according to the developmental synchrony of pronuclei. The developmental potential of zygotes from these two groups was observed. Embryos for transfer were selected initially by embryo growth rate and morphology, secondarily by zygote grade. The clinical pregnancy rates and implantation rates were compared according to whether the embryos from synchronous group were transferred.
There were 2714 normal zygotes, the good-quality embryos (> or = 6 cells, grade I - II) rate of the synchronous group (41.88%, 743/1774) was significantly higher (P < 0.001) than the nonsynchronous group (33.94%, 319/940). Totally 395 cycles transferred at least one embryo from synchronous group, the clinical pregnancy rate was 47.85% (189/395) and implantation rate was 27.49% (273/993). There was no significant difference from 39 cycles which did not transfer embryos from nonsynchronous group. The clinical pregnancy rate was 43.59% (17/39) and implantation rate was 25.00% (21/84).
The data indicate that there are no significant differences in pregnancy rates and implantation rates between different zygote grade when selecting embryos for transfer by combined grading.
评估胚胎生长速率与形态以及合子原核形态综合评分的价值,并在临床体外受精(IVF)/卵胞浆内单精子注射(ICSI)中选择用于移植的胚胎。
在这项回顾性研究中,分析了2003年5月至2003年12月期间434个IVF/ICSI治疗周期中的2714个正常合子(2个原核)。根据原核的发育同步性将这些合子分为两组(同步组和不同步组)。观察这两组合子的发育潜能。首先根据胚胎生长速率和形态选择用于移植的胚胎,其次根据合子等级进行选择。根据是否移植同步组合子来源的胚胎比较临床妊娠率和着床率。
共有2714个正常合子,同步组优质胚胎(≥6细胞,I-II级)率(41.88%,743/1774)显著高于不同步组(33.94%,319/940)(P<0.001)。共有395个周期至少移植了1个同步组合子来源的胚胎,临床妊娠率为47.85%(189/395),着床率为27.49%(273/993)。与未移植不同步组合子来源胚胎的39个周期相比,差异无统计学意义。临床妊娠率为43.59%(17/39),着床率为25.00%(21/84)。
数据表明,在通过综合评分选择用于移植的胚胎时,不同合子等级之间的妊娠率和着床率无显著差异。